We find that BACH1 aggravates benign diseases mainly by inhibiting the expression of downstream molecules, such as transcriptional inhibition of HO-1, and promotes cancer progression of the digestive system mainly by upregulating the expression of downstream molecules, such as transcriptional activation of IGF1R. Here, BACH1 is linked to cancer.